BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18279805)

  • 1. Inhibition of the antigen-induced activation of RBL-2H3 cells by sinomenine.
    Huang F; Yamaki K; Tong X; Fu L; Zhang R; Cai Y; Yanagisawa R; Inoue K; Takano H; Yoshino S
    Int Immunopharmacol; 2008 Mar; 8(3):502-7. PubMed ID: 18279805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gab2 antisense oligonucleotide blocks rat basophilic leukemic cell functions.
    Chan JH; Liao W; Lau HY; Wong WS
    Int Immunopharmacol; 2007 Jul; 7(7):937-44. PubMed ID: 17499196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the antigen-induced activation of RBL-2H3 cells by Gab2 siRNA.
    Huang F; Tong X; Deng H; Fu L; Zhang R
    Cell Mol Immunol; 2008 Dec; 5(6):433-8. PubMed ID: 19118509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcepsilonRI signaling in mast cells.
    Han EH; Park JH; Kim JY; Jeong HG
    Food Chem Toxicol; 2009 Jul; 47(7):1659-66. PubMed ID: 19394399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the antigen-stimulated RBL-2H3 mast cell activation by Artekeiskeanol A.
    Hong J; Sasaki H; Hirasawa N; Ishihara K; Kwak JH; Zee O; Schmitz FJ; Seyama T; Ohuchi K
    Planta Med; 2009 Nov; 75(14):1494-8. PubMed ID: 19572256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xestospongin C, a novel blocker of IP3 receptor, attenuates the increase in cytosolic calcium level and degranulation that is induced by antigen in RBL-2H3 mast cells.
    Oka T; Sato K; Hori M; Ozaki H; Karaki H
    Br J Pharmacol; 2002 Apr; 135(8):1959-66. PubMed ID: 11959799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinomenine potentiates degranulation of RBL-2H3 basophils via up-regulation of phospholipase A2 phosphorylation by Annexin A1 cleavage and ERK phosphorylation without influencing on calcium mobilization.
    Huang L; Li T; Zhou H; Qiu P; Wu J; Liu L
    Int Immunopharmacol; 2015 Oct; 28(2):945-51. PubMed ID: 25939534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TA-270 [4-hydroxy-1-methyl-3-octyloxy-7-sinapinoylamino-2(1H)-quinolinone], an anti-asthmatic agent, inhibits leukotriene production induced by IgE receptor stimulation in RBL-2H3 cells.
    Ishiwara M; Aoki Y; Takagaki H; Ui M; Okajima F
    J Pharmacol Exp Ther; 2003 Nov; 307(2):583-8. PubMed ID: 12970384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PICOT, protein kinase C theta-interacting protein, is a novel regulator of FcepsilonRI-mediated mast cell activation.
    Kato N; Motohashi S; Okada T; Ozawa T; Mashima K
    Cell Immunol; 2008 Jan; 251(1):62-7. PubMed ID: 18479680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licarin A is a candidate compound for the treatment of immediate hypersensitivity via inhibition of rat mast cell line RBL-2H3 cells.
    Matsui T; Ito C; Masubuchi S; Itoigawa M
    J Pharm Pharmacol; 2015 Dec; 67(12):1723-32. PubMed ID: 26376734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of water-soluble cigarette smoke extracts upon the release of beta-hexosaminidase from RBL-2H3 basophilic leukaemia cells in response to substance P, compound 48/80, concanavalin A and antigen stimulation.
    Fowler CJ; Sandberg M; Tiger G
    Inflamm Res; 2003 Nov; 52(11):461-9. PubMed ID: 14652680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of natsudaidain isolated from Citrus plants on TNF-alpha and cyclooxygenase-2 expression in RBL-2H3 cells.
    Matsui T; Ito C; Itoigawa M; Okada T; Furukawa H
    J Pharm Pharmacol; 2009 Jan; 61(1):109-14. PubMed ID: 19126304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Th1 and Th2 immune responses in mice by Sinomenine, an alkaloid extracted from the chinese medicinal plant Sinomenium acutum.
    Feng H; Yamaki K; Takano H; Inoue K; Yanagisawa R; Yoshino S
    Planta Med; 2006 Dec; 72(15):1383-8. PubMed ID: 17091433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steel factor enhances supraoptimal antigen-induced IL-6 production from mast cells via activation of protein kinase C-beta.
    Fehrenbach K; Lessmann E; Zorn CN; Kuhny M; Grochowy G; Krystal G; Leitges M; Huber M
    J Immunol; 2009 Jun; 182(12):7897-905. PubMed ID: 19494314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAT is essential for the mast cell stabilising effect of tHGA in IgE-mediated mast cell activation.
    Tan JW; Israf DA; Md Hashim NF; Cheah YK; Harith HH; Shaari K; Tham CL
    Biochem Pharmacol; 2017 Nov; 144():132-148. PubMed ID: 28813645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory activity of atractylenolide Ш, a sesquiterpenoid, on IgE-mediated mast cell activation and passive cutaneous anaphylaxis (PCA).
    Zhang NN; Park DK; Park HJ
    J Ethnopharmacol; 2013 Jan; 145(1):278-85. PubMed ID: 23149288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone up-regulates A3 adenosine receptors in rat basophilic leukemia (RBL-2H3) cells.
    Ramkumar V; Wilson M; Dhanraj DN; Gettys TW; Ali H
    J Immunol; 1995 May; 154(10):5436-43. PubMed ID: 7730645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anthocyanidin inhibits immunoglobulin E-mediated allergic response in mast cells].
    Jin GR; Hong H; Jin GY; Li YZ; Li GZ; Yan GH
    Yao Xue Xue Bao; 2012 Jan; 47(1):34-8. PubMed ID: 22493802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha-galactosyl derivatives of ganglioside GD(1b) are essential for the organization of lipid rafts in RBL-2H3 mast cells.
    Silveira e Souza AM; Mazucato VM; de Castro RO; Matioli F; Ciancaglini P; de Paiva Paulino T; Jamur MC; Oliver C
    Exp Cell Res; 2008 Aug; 314(13):2515-28. PubMed ID: 18585706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cyclosporin and tacrolimus (FK506) on the antigen-induced mediator release, membrane potential and 86Rb+/K+ and Ca2+ fluxes in the RBL-2H3 cell line.
    Narenjkar J; Assem el-SK; Wan BY; Marsh S; Ezeamuzie CI
    Int Immunopharmacol; 2006 May; 6(5):742-9. PubMed ID: 16546704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.